An International Journal of Otorhinolaryngology Clinics

Register      Login

VOLUME 14 , ISSUE 3 ( September-December, 2022 ) > List of Articles


Lemierre's Syndrome in COVID Pandemic: Is there an Association?

Picardo Naina, Nithish Raj, John AJ Prakash, Abi Manesh

Keywords : Klebsiella, Lemierre's syndrome, Neck swelling, SARS-CoV-2, Type 2 diabetes

Citation Information : Naina P, Raj N, Prakash JA, Manesh A. Lemierre's Syndrome in COVID Pandemic: Is there an Association?. Int J Otorhinolaryngol Clin 2022; 14 (3):114-116.

DOI: 10.5005/jp-journals-10003-1401

License: CC BY-NC 4.0

Published Online: 20-03-2023

Copyright Statement:  Copyright © 2022; The Author(s).


Background: Lemierre's syndrome is an uncommon life-threatening condition characterized by septic thrombophlebitis of the internal jugular vein (IJV), anaerobic sepsis, and metastatic infections. Case description: A 57-year-old diabetic male presented to the emergency department with progressively increasing left-sided neck swelling. A contrast-enhanced computed tomography of the neck revealed an air-containing abscess showed a long-segment thrombus in the left internal jugular vein with septic embolization to the right upper lung. He was also positive for SARS-CoV-2 infection. He underwent emergency drainage of the abscess along with culture appropriate antibiotics. Two days postprocedure, he developed atrial fibrillation and received anticoagulation treatment for 3 months. Discussion: This case report adds to the growing body of literature of co-occurrence of Lemierre's syndrome in SARS-CoV-2 infection and discusses the possible associations between the two. Besides, it also highlights Klebsiella pneumoniae as an uncommon pathogen causing Lemierre's syndrome.

PDF Share
  1. Gama R, Sousa M, Castro F, et al. Lemierre's syndrome: a forgotten life-threatening entity. BMJ Case Rep 2020;13(10):e236201. DOI: 10.1136/bcr-2020-236201.
  2. Lemierre A. On certain septicaemias due to anaerobic organisms. Lancet 1936;227(5874):701–703. DOI: 10.1016/S0140-6736(00)57035-4.
  3. Patel PN, Levi JR, Cohen MB. Lemierre's syndrome in the pediatric population: trends in disease presentation and management in literature. Int J Pediatr Otorhinolaryngol 2020;136:110213. DOI: 10.1016/j.ijporl.2020.110213.
  4. Chaker K, Berrada O, Lyoubi M, et al. Lemierre's syndrome or re-emerging disease: case report and literature review. Int J Surg Case Rep 2021;78:151–154. DOI: 10.1016/j.ijscr.2020.12.015.
  5. Syed MI, Baring D, Addidle M, et al. Lemierre syndrome: two cases and a review. Laryngoscope 2007;117(9):1605–1610. DOI: 10.1097/MLG.0b013e318093ee0e.
  6. Gore MR. Lemierre syndrome: a meta-analysis. Int Arch Otorhinolaryngol 2020;24(3):e379–e385. DOI: 10.1055/s-0039-3402433.
  7. Lee WS, Wang FD, Shieh YH, et al. Lemierre syndrome complicating multiple brain abscesses caused by extended-spectrum β-lactamase-producing Klebsiella pneumoniae cured by fosfomycin and meropenem combination therapy. J Microbiol Immunol Infect 2012;45(1):72–74. DOI: 10.1016/j.jmii.2011.09.012.
  8. Tsai YJ, Lin YC, Harnnd DJ, et al. A Lemierre syndrome variant caused by Klebsiella pneumoniae. J Formos Med Assoc 2012;111(7):403–405. DOI: 10.1016/j.jfma.2012.03.012.
  9. Chua SH, Ong SCL, Liew YH. Variant of Lemierre's syndrome with internal jugular vein aneurysm. BMJ Case Rep 2017;2017: bcr2017223371. DOI: 10.1136/bcr-2017-223371.
  10. Adedeji A, Chukwura O, Obafemi T, et al. Anticoagulation strategies in the management of Lemierre syndrome: a systematic review of the literature. Ann Pharmacother 2021;55(5):658–665. DOI: 10.1177/1060028020957620.
  11. Karn MN, Johnson NP, Yaeger SK, et al. A teenager with fever, chest pain, and respiratory distress during the coronavirus disease 2019 pandemic: a lesson on anchoring bias. J Am Coll Emerg Physicians Open 2020;1(6):1392–1394. DOI: 10.1002/emp2.12261.
  12. Repper DC, Arrieta AC, Cook JE, et al. A case of Lemierre syndrome in the era of COVID-19: all that glitters is not gold. Pediatr Infect Dis J 2020;39(12):e445–e447. DOI: 10.1097/INF.0000000000002939.
  13. Sabaka P, Kachlíková M, Bendžala M, et al. Lemierre syndrome caused by Klebsiella pneumoniae complicated by epidural abscess–case report. IDCases 2019;19:e00664. DOI: 10.1016/j.idcr.2019.e00664.
  14. Howley F, O'Doherty L, McEniff N, et al. Late presentation of “Lemierre's syndrome”: how a delay in seeking healthcare and reduced access to routine services resulted in widely disseminated Fusobacterium necrophorum infection during the global COVID-19 pandemic. BMJ Case Rep 2020;13(10):e239269. DOI: 10.1136/bcr-2020-239269.
  15. Ierardi AM, Gaibazzi N, Tuttolomondo D, et al. Deep vein thrombosis in COVID-19 patients in general wards: prevalence and association with clinical and laboratory variables. Radiol Med 2021;126(5):722–728. DOI: 10.1007/s11547-020-01312-w.
  16. Helms J, Tacquard C, Severac F, et al. High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study. Intensive Care Med 2020;46(6):1089–1098. DOI: 10.1007/s00134-020-06062-x. Epub 2020 May 4.
  17. Nygren D, Elf J, Torisson G, et al. Jugular vein thrombosis and anticoagulation therapy in Lemierre's syndrome–a post hoc observational and population-based study of 82 patients. Open Forum Infect Dis 2020;8(1):ofaa585. DOI: 10.1093/ofid/ofaa585.
  18. Kollias A, Kyriakoulis KG, Dimakakos E, et al. Thromboembolic risk and anticoagulant therapy in COVID-19 patients: emerging evidence and call for action. Br J Haematol 2020;189(5):846–847. DOI: 10.1111/bjh.16727.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.